BIOMAT Database Logo BIOMAT Database Logo

Mechanisms of action of new antitumor promoters. 1993

M Suganuma, and S Yoshizawa, and J Yatsunami, and S Nishiwaki, and H Furuya, and S Okabe, and R Nishiwaki-Matsushima, and K Frenkel, and W Troll, and A K Verma
Cancer Prevention Division, National Cancer Center Research Institute, Tokyo, Japan.

UI MeSH Term Description Entries
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D002392 Catechin An antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms. Catechinic Acid,Catechuic Acid,(+)-Catechin,(+)-Cyanidanol,(+)-Cyanidanol-3,(-)-Epicatechin,(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,5,7-chromanetriol,2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-,3,3',4',5,7-Flavanpentol,Catergen,Cianidanol,Cyanidanol-3,Epicatechin,KB-53,Z 7300,Zyma,Cyanidanol 3,KB 53,KB53
D004224 Diterpenes Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate. Diterpene,Diterpenes, Cembrane,Diterpenes, Labdane,Diterpenoid,Labdane Diterpene,Norditerpene,Norditerpenes,Norditerpenoid,Cembranes,Diterpenoids,Labdanes,Norditerpenoids,Cembrane Diterpenes,Diterpene, Labdane,Labdane Diterpenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012717 Sesquiterpenes Fifteen-carbon compounds formed from three isoprenoid units with general formula C15H24. Farnesanes,Farnesene,Farnesenes,Sesquiterpene,Sesquiterpene Derivatives,Sesquiterpenoid,Sesquiterpenoids,Derivatives, Sesquiterpene
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D016588 Anticarcinogenic Agents Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. Anti-Carcinogenic Agents,Anti-Carcinogenic Drugs,Anti-Carcinogenic Effect,Anti-Carcinogenic Effects,Anticarcinogenic Drugs,Anticarcinogenic Effect,Anticarcinogenic Effects,Anticarcinogens,Agents, Anti-Carcinogenic,Agents, Anticarcinogenic,Anti Carcinogenic Agents,Anti Carcinogenic Drugs,Anti Carcinogenic Effect,Anti Carcinogenic Effects,Drugs, Anti-Carcinogenic,Drugs, Anticarcinogenic,Effect, Anti-Carcinogenic,Effect, Anticarcinogenic,Effects, Anti-Carcinogenic,Effects, Anticarcinogenic
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M Suganuma, and S Yoshizawa, and J Yatsunami, and S Nishiwaki, and H Furuya, and S Okabe, and R Nishiwaki-Matsushima, and K Frenkel, and W Troll, and A K Verma
Possible molecular mechanisms of action of tumor promoters.
January 1982, Carcinogenesis; a comprehensive survey,
M Suganuma, and S Yoshizawa, and J Yatsunami, and S Nishiwaki, and H Furuya, and S Okabe, and R Nishiwaki-Matsushima, and K Frenkel, and W Troll, and A K Verma
The mechanisms of action of antitumor compounds.
March 1977, National Cancer Institute monograph,
M Suganuma, and S Yoshizawa, and J Yatsunami, and S Nishiwaki, and H Furuya, and S Okabe, and R Nishiwaki-Matsushima, and K Frenkel, and W Troll, and A K Verma
Chemistry and mechanisms of action of antitumor antibiotics.
March 1977, National Cancer Institute monograph,
M Suganuma, and S Yoshizawa, and J Yatsunami, and S Nishiwaki, and H Furuya, and S Okabe, and R Nishiwaki-Matsushima, and K Frenkel, and W Troll, and A K Verma
Antioxidants as antitumor promoters.
January 1986, Basic life sciences,
M Suganuma, and S Yoshizawa, and J Yatsunami, and S Nishiwaki, and H Furuya, and S Okabe, and R Nishiwaki-Matsushima, and K Frenkel, and W Troll, and A K Verma
Antitumor activities of IL-12 and mechanisms of action.
January 1997, Chemical immunology,
M Suganuma, and S Yoshizawa, and J Yatsunami, and S Nishiwaki, and H Furuya, and S Okabe, and R Nishiwaki-Matsushima, and K Frenkel, and W Troll, and A K Verma
[Mode of action of new antitumor compounds].
January 1982, Revista espanola de oncologia,
M Suganuma, and S Yoshizawa, and J Yatsunami, and S Nishiwaki, and H Furuya, and S Okabe, and R Nishiwaki-Matsushima, and K Frenkel, and W Troll, and A K Verma
Mechanisms of the antitumor action of the new antibiotic NC0604, a member of the bleomycin family.
September 2010, Oncology reports,
M Suganuma, and S Yoshizawa, and J Yatsunami, and S Nishiwaki, and H Furuya, and S Okabe, and R Nishiwaki-Matsushima, and K Frenkel, and W Troll, and A K Verma
Mechanisms of action of antitumor antibiotic inhibitors of protein synthesis.
January 1974, Cancer chemotherapy reports,
M Suganuma, and S Yoshizawa, and J Yatsunami, and S Nishiwaki, and H Furuya, and S Okabe, and R Nishiwaki-Matsushima, and K Frenkel, and W Troll, and A K Verma
[Study of the mechanisms of antitumor action of alkylating metabolites].
January 1960, Vestnik Akademii meditsinskikh nauk SSSR,
M Suganuma, and S Yoshizawa, and J Yatsunami, and S Nishiwaki, and H Furuya, and S Okabe, and R Nishiwaki-Matsushima, and K Frenkel, and W Troll, and A K Verma
Antitumor effect of oleic acid; mechanisms of action: a review.
January 2012, Nutricion hospitalaria,
Copied contents to your clipboard!